The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
Appointment of Chief Medical Officer to
Dr. D'Ambrosio is one of the world's leading campaigners for policy reform on the use of medical cannabis. A surgeon with over 30 years' experience, he has studied the effects of cannabis-based medicine for different purposes such as chronic pain and post-traumatic stress disorder. For the last six years, he has dedicated his medical practice to helping patients in the US incorporate medical cannabis into the everyday care. Moreover, he hopes to educate individuals and authorities on the benefits of medicinal cannabis, through his insights as a doctor, advocate and entrepreneur.
In November of last year, Dr. D'Ambrosio spoke at the
"I am very glad to join
"We are leaving behind myths and misconceptions, which largely benefits patients who could only rely on big pharma to treat their conditions. This represents an opportunity not only for investors, but also to build a more comprehensive range of healthcare options in order to help patients to achieve a better quality of life."
"Dr. D'Ambrosio's extensive experience and specialisation will prove invaluable to our Company as we develop a full strategy to deploy medicinal cannabis as a therapy."
The Company has implemented Farmer 3.0, a blockchain-powered ecosystem that connects all market participants to facilitate commercial transactions.
Building on well-established connections and technology expertise, the Company has expanded its operations into the medicinal cannabis market with a strategy to produce and process cannabis-based products via licences in
For more information, visit: http://www.blockcommodities.com
The Directors of the Company accept responsibility for the content of this announcement.
For further information, please contact:
|EQS News ID:||818441|
|End of Announcement|